Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

  1. Home
  2. PAAB Q&A
  3. Claims & Support/References for Claims
  4. References and Attestation Letters for Broad Coverage Claims
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

References and Attestation Letters for Broad Coverage Claims

Scheduled Pinned Locked Moved Claims & Support/References for Claims
1 Posts 1 Posters 9 Views
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • D Offline
    D Offline
    dmauri
    wrote last edited by
    #1

    We're interested in developing a single printed APS that can promote updated public coverage (a new patient population) in different provinces. The intent is to use a broad message of "covered in DiseaseX in your province" (without specifying the province), and only disseminate the APS in provinces for which the coverage update has been confirmed and published. This is similar PAAB forum topic 196 (https://forum.paab.ca/topic/196). Due to financial constraints, we are unable to make a different APS for each province (10 different APSs).

    We expect online formularies for various provinces to publish criteria much later than the actual formulary listing. Therefore, we will likely need to use an attestation letter as our reference for the formulary criteria + listings.

    My questions are:
    A) For our initial submission, do we still have to provide the anticipated public coverage criteria for each province in which the APS will be disseminated?
    B) For final approval, do we still need to provide the confirmed public coverage for each province in which the APS will be disseminated? Our concern is that this delays the piece for provinces that get the updated coverage earlier.

    Thank you in advance!

    1 Reply Last reply
    0
    Reply
    • Reply as topic
    Log in to reply
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes


    • Login

    • Don't have an account? Register

    • Login or register to search.
    • First post
      Last post
    0
    • Categories
    • Recent
    • Tags
    • Popular
    • Users
    • Groups